For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
Trump's Desire to Reopen the Country by Easter May Not Be Far-Fetched
There are reasons to hope this crisis may pass sooner and with less economic and human damage than we are being led to believe.
What If Democrats Stonewalled the Drug Companies' Response to COVID-19?
The Democrats' shameless stonewalling of a coronavirus relief package in order to pass their progressive wish list demonstrates why we cannot let Congress control the drug industry.
Looking Ahead at Health Plan Options
This year has been labeled a referendum on just about everything, but healthcare is one thing that will definitely drive people to the polls.
One Coronavirus Silver Lining: Fewer Colds and Flu Cases
It's really hard finding a silver lining to the coronavirus outbreak and the government's response, but maybe there will be hundreds of thousands of fewer cases of the cold and flu.
Hey, Bernie, Check Out Government's 10 Most Wanted 'Medi-crooks'
Bernie Sanders claims government-run health care is more efficient, but he never addresses the rampant fraud in the two biggest government health care programs: Medicare and Medicaid.
Trump Should Dust Off Last Year's Drug Reform Plan
By reintroducing his rebate rule, President Trump could lower drug prices by excluding the middlemen who gobble up much of the current price-discount savings.
What Foreign Steel, NATO and Prescription Drugs Have in Common
If the president doesn't want to import price-controlled, foreign-made steel, then why does he want to import price-controlled prescription drugs?
What Kind of Disrupter Would President Sanders Be?
Being a disrupter could be either positive or negative, depending on whether and how a voter thinks the country needs disrupting.
An Easily Forgotten Point: Price Is Not the Same as Spending
Efforts to control prescription-drug prices by setting prices through a government mandate are not likely to control overall prescription-drug spending.
'Greedy' Drugmakers Pour Money into Finding a Coronavirus Fix
Governments can't act as quickly as private sector drug companies when it comes to finding a vaccine for the coronavirus or any other epidemic.


